International Journal of STD & AIDS > Volume 18, Number 12 > Pp. 829-831

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coyne, K. M Articles by Barton, S Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Original research articles

Patient-delivered partner medication in the UK: an unlawful but popular choice

Katherine M Coyne, C E Cohen, N A Smith, S Mandalia and S Barton

HIV/GUM Directorate, Chelsea & Westminster NHS Foundation Trust, London, UK; HIV/GUM Directorate, Chelsea & Westminster NHS Foundation Trust, London, UK; HIV/GUM Directorate, Chelsea & Westminster NHS Foundation Trust, London, UK; HIV/GUM Directorate, Chelsea & Westminster NHS Foundation Trust, London, UK; HIV/GUM Directorate, Chelsea & Westminster NHS Foundation Trust, London, UK

Current methods of contact tracing are only partially effective. Patient-delivered partner medication (PDPM), in which patients are dispensed antibiotics for their sexual partner(s), has been shown to reduce persistent and recurrent infections. We performed a questionnaire to canvass opinions of UK staff and patients about PDPM. The response rate was 72% (88/122) for staff and 90% (473/525) for patients. The majority of staff (81%) thought that PDPM would be acceptable to patients, and should be combined with written information and a recommendation to attend a clinic. Patients were mostly (59%) in favour of PDPM, 87% thought it would make it easier to abstain from sex during treatment, and 94% indicated that after being given antibiotics by a partner, they would attend a clinic for tests. Concerns expressed by staff and patients included drug allergies, potential lack of information provided to partners, management of complicated infection, pregnancy and medicolegal implications.

Key Words: CONTACT TRACING • SEXUAL PARTNERS • ATTITUDE OF HEALTH PERSONNEL • PATIENTS • SEXUALLY TRANSMITTED DISEASES

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L Sutcliffe, M G Brook, J L Chapman, J M Cassell, and C S Estcourt Is accelerated partner therapy a feasible and acceptable strategy for rapid partner notification in the UK?: a qualitative study of genitourinary medicine clinic attenders Int J STD AIDS, September 1, 2009; 20(9): 603 - 606. [Abstract] [Full Text] [PDF]

				K M Coyne, S E Barton, N A Smith, and C E Cohen Azithromycin without a prescription increases access and choice for patients Int J STD AIDS, December 1, 2008; 19(12): 870 - 870. [Full Text] [PDF]

				S. Shivasankar, R. Challenor, and R. Ekanayaka Patient-delivered partner therapy in the UK: what do patients think? Int J STD AIDS, July 1, 2008; 19(7): 433 - 436. [Abstract] [Full Text] [PDF]

				S. Shivasankar and R. Challenor Patient-delivered partner therapy in the UK: what do the professionals think? Int J STD AIDS, July 1, 2008; 19(7): 437 - 440. [Abstract] [Full Text] [PDF]

				A Markos Patient-delivered partner medication: the antagonism of clinical standards and good medical practice Int J STD AIDS, April 1, 2008; 19(4): 283 - 284. [Full Text] [PDF]